In a patent litigation among medical device manufacturers, CRA was asked to assess damages suffered by plaintiff for alleged infringement of patents on bone compression plates. CRA examined lost profit and reasonable royalty damages, finding that a royalty would have been capped at the cost of implementing a viable non-infringing alternative. CRA provided an expert report and deposition testimony.
Recent trends in Rule 702 decisions – 2024
In this CRA Insights, we update the Rule 702 decision trends in last year’s Insights with 2023 data.[1] We also provide descriptions of four specific...